SAPPHIRE ORGANICS
Natural health product licensed in Canada
- Other names
- Sapphire Organics L-Arginine
- Licence holder
- Sapphire Organics Inc.
- NPN or DIN-HM
- 80085835
- Status
- Active licence
- Licence date
- 4 June 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| L-arginine Source : Monohydrochlorure de L-arginine | 1,000 milligramme | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Hypromellose, Stéarate de magnésium, Palmitate d'ascorbyle, farine de riz
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | minimum: 1 Tous les jours ; maximum: 6 Tous les jours |
Uses authorised in Canada
May help support a modest improvement in exercise capacity in individuals with stable cardiovascular diseases (CVD) (Doutreleau et al. 2010, Doutreleau et al. 2006, Lim et al. 2004, Palloshi et al. 2004, Bode-Boger et al. 2003, Lekakis et al. 2002, Parker et al. 2002, Sydow et al. 2002, Nagaya et al. 2001, Bednarz et al. 2000, Hambrecht et al. 2000, Tangphao et al. 1999, Lerman et al. 1998, Clarkson et al. 1996, Rector et al. 1996) L-Arginine is a non-essential amino acid that is involved in protein synthesis (Shils et al. 2006, IOM 2005, Groff and Gropper 2000).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you have had a heart attack/myocardial infarction (Shulman et al. 2006).
- Effets indésirables connus
Some people may experience gastrointestinal discomfort (such as diarrhea) (Grimble 2007, IOM 2005, Evans et al. 2004, Clarkson et al. 1996).
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding For products providing 0.42 - 21 Grams per day: Consult a health care practitioner if your cardiovascular condition worsens. For products providing 0.42 - 21 Grams per day: Consult a health care practitioner prior to use if you have a renal/kidney disease or if you are following a low protein diet (Goldman and Ausiello 2004) For products providing 0.42 - 21 Grams per day: Consult a health care practitioner prior to use if you suffer from a cardiovascular disease and are attempting an increase in physical activity (Doutreleau et al. 2010, Doutreleau et al. 2006, Shulman et al. 2006, Nagaya et al. 2001, Bednarz et al. 2000, Ceremuzynski et al. 1997, Rector et al. 1996) For products providing 0.42 - 21 Grams per day: Consult your health care practitioner prior to use if you are taking medication for cardiovascular diseases, erectile dysfunction, and/or blood thinners (Huynh et al. 2002, Parker et al. 2002, Siani et al. 2000, Adams et al. 1995).
Source
Official Health Canada record, licence 80085835
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.